Real life data from Turkey regarding the impact of first-line sunitinib and pazopanib in metastatic renal cell cancer.

Basit Öğe Kaydı
dc.authorid0000-0002-7649-1075
dc.authorid0000-0001-6126-5377
dc.contributor.authorIsik, Ulas
dc.contributor.authorKöstek, Osman
dc.contributor.authorDemiray, Gokcen
dc.contributor.authorDirican, Ahmet
dc.contributor.authorSimsek, Melih
dc.contributor.authorBuyuksimsek, Mahmut
dc.contributor.authorUcar, Gokhan
dc.date.accessioned2025-05-10T19:34:29Z
dc.date.issued2019
dc.departmentİstanbul Medeniyet Üniversitesi
dc.descriptionAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- MAY 31-JUN 04, 2019 -- Chicago, IL
dc.description.abstract[No abstract available]
dc.description.sponsorshipAmer Soc Clin Oncol
dc.identifier.doi10.1200/JCO.2019.37.15_suppl.e16075
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue15
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1200/JCO.2019.37.15_suppl.e16075
dc.identifier.urihttps://hdl.handle.net/20.500.14730/8542
dc.identifier.volume37
dc.identifier.wosWOS:000487345801503
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherAmer Soc Clinical Oncology
dc.relation.ispartofJournal of Clinical Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.titleReal life data from Turkey regarding the impact of first-line sunitinib and pazopanib in metastatic renal cell cancer.
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu